As Baidu raced to develop its ChatGPT equivalent, employees working to advance AI technologies for drug discovery had to suspend their research and cede their computer chips to develop the chatbot instead. The current AI paradigm is also choking off alternative paths to AI development. The number of independent researchers not affiliated with or receiving funding from the tech industry has rapidly dwindled, diminishing the diversity of ideas in the field not tied to short-term commercial benefit.
